HUS 080-2024 Genetic testing for rare diseases, various methods
HUS 080-2024 Genetic testing for rare diseases, various methods The Procurement Entities HUS Group (later also ”HUS”) and ISLAB requested tenders for genetic testing for rare diseases using various methods. The procurement included the following tests: 1. Ataxia repeat analysis by NGS 2. Repeat expansion analysis (UGT1A1) 3. Repeat expansion analysis (CANVAS) 4. Repeat expansion analysis (MUC1) 5. Genetic testing for hereditary Alpha Tryptasemia 6. MLH1 promoter methylation analysis 7. Beckwith-Wiedemann syndrome testing 8. Cystic fibrosis (CF-EU2) 9. L…
- Ostaja
- HUS Group
- Julkaistu
- 2025-11-11
- Arvo
- 1 100 000 EUR
- Ilmoitus
- 33769
Voittajat ja hankinnan osat
HUS 080-2024 Genetic testing for rare diseases, various methods
The Procurement Entities HUS Group (later also ”HUS”) and ISLAB requested tenders for genetic testing for rare diseases using various methods. The procurement included the following tests: 1. Ataxia repeat analysis by NGS 2. Repeat expansion analysis (UGT1A1) 3. Repeat expansion analysis (CANVAS) 4. Repeat expansion analysis (MUC1) 5. Genetic testing for hereditary Alpha Tryptasemia 6. MLH1 promoter methylation analysis 7. Beckwith-Wiedemann syndrome testing …
- Centogene GmbH (DE813228872) – 550 000 €
- MVZ Martinsried GmbH (DE301782597) – 550 000 €